Geneva, Switzerland and Boston, MA – December 1, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical […]
COPENHAGEN, Denmark, Oct. 21, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]
A team of investigators at Washington University School of Medicine in St. Louis led by Peter Fischer, PhD and Gary […]
The University of Florida won a $2.3 million grant in its quest to investigate liver scarring and inflammation triggered by […]
By some estimates, the biomedical clinical research and development market total over $100 billion worldwide and those regions that evolve […]
Third Quarter 2020 Revenue Increases 17% Year-Over-Year to $40.0 Million Third Quarter 2020 Net Income of $5.0 Million, or EPS […]
PPARs are shown to be attractive therapeutic targets for the treatment of NASH, producing beneficial effects on the liver, improving […]
Geneva, Switzerland and Boston, MA – October 22, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and […]
Geneva, Switzerland and Boston, MA – October 20, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and […]
Duke Clinical Research Institute (DCRI), an prestigious research organization, recently selected a mid-market contract research organization (CRO) out of Sweden […]
